Tilray Brands, Inc. - Common Stock (TLRY)

The past, present and futur eof the Canasian cannabis sector.

Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B.

The past, present, and future of the Canadian cannabis sector.

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) fell 19.7% in the afternoon session after the company reported weak fiscal third-quarter 2025 results that missed analysts' sales and EBITDA estimates, signaling ongoing challenges in growing its top line. 

Tilray Brands missed Q3 revenue expectations and lowered FY25 outlook, while beverage and wellness units posted year-over-year revenue increases.

Beer, wine, and spirits company Constellation Brands (NYSE:STZ) will be reporting results tomorrow after market close. Here’s what you need to know.

Cannabis company Tilray Brands (NASDAQ:TLRY) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $185.8 million. The company’s full-year revenue guidance of $875 million at the midpoint came in 2% below analysts’ estimates. Its non-GAAP loss of $0 per share was significantly above analysts’ consensus estimates.

Cannabis company Tilray Brands (NASDAQ:TLRY) will be reporting results tomorrow before the bell. Here’s what investors should know.

The stock has performed horribly but would make a comeback story for the ages.

Tilray Brands transitions its flagship cannabis strain, Good Supply Jean Guy, to Québec.